2015 was the year marked by the Bulgarian government’s upgrade of the pricing and reimbursement system by introducing changes in the Law on the ...
For pharmaceutical products we also provide support for pricing and reimbursement:
– Advice on local pricing and reimbursement issues and avoiding the pitfalls of the national external and internal reference systems;
– Preparation of price approval and positive drug list applications;
– Translation of all related documentation;
– Timely follow up and communication with experts and administrative support at all levels.
We are currently expanding our regulatory expertise for Russia and other CIS countries, as well as selected MENA markets via partnerships with qualified external experts.